MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Inhibition of LRRK2 kinase activity promotes glucocerebrosidase transport to the lysosomes in primary monocyte-derived macrophages from patients with GBA-associated Parkinson’s disease

    K. Basharova, A. Bezrukova, A. Izyumchenko, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: The aim was to evaluate the effectiveness of leucine-rich repeat kinase 2 (LRRK2) kinase activity inhibition in restoring transport of the enzyme glucocerebrosidase (GCase),…
  • 2023 International Congress

    Identification of potential oxidative biomarkers in saliva of Parkinson’s disease patients

    J. Rungta, A. Roy, S. Choudhury, S. Ansari, P. Chatterjee, R. Khatun, R. Pramanik, S. Dey, H. Kumar (Kolkata, India)

    Objective: The goal of this study is to ascertain whether salivary oxidative markers are altered in Parkinson’s Disease (PD) and if there is an association of these markers with disease…
  • 2023 International Congress

    Chorea following SARS-CoV-2 infection and vaccination: a systematic review

    R. Bilavu, M. Simu, E. Rosca (Timișoara, Romania)

    Objective: We aimed to investigate and compare data on chorea following SARS-CoV-2 infection and vaccination to provide an extensive perspective on this pathology and to…
  • 2023 International Congress

    Evaluation of small extracellular vesicles derived miRNA as biomarkers for Parkinson’s disease: comparison with plasma miRNA

    S. Rai, P. Bharti, R. Singh, R. Rajan, S. Kumar (New Delhi, India)

    Objective: To identify differentially expressed small extracellular vesicles (sEV) derived miRNAs in Parkinson’s disease using small RNA-sequencing and to evaluate their potential as biomarker targets.…
  • 2023 International Congress

    Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

    P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)

    Objective: To analyse the feasibility and effects on cognitive- and non-cognitive outcomes, and prediction of responsiveness of a computerized cognitive training (CT) in comparison to…
  • 2023 International Congress

    Local field potentials in the subthalamic nucleus of patients with Parkinson’s disease – Effect of the deep brain stimulation

    S. Taguchi, T. Nakura, H. Saiki, S. Miyachi, M. Doyu (Nagakute, Japan)

    Objective: To obtain knowledge that would lead to the usage of local field potentials (LFP) in the deep brain stimulation therapy (DBS). Background: The LFP…
  • 2023 International Congress

    Pain and quality of life in cervical dystonia

    L. Herrmann, L. Vorbeck, A. Palisi, A. Maurer, S. Lezius, J. Mallwitz, M. Gelderblom, S. Zittel (Hamburg, Germany)

    Objective: To evaluate different aspects of quality of life (QoL) and pain prevalence, characteristics and influencing factors in patients with cervical dystonia (CD) before and…
  • 2023 International Congress

    Classification and genotype-phenotype relationships of GBA1 variants and Parkinson’s disease: MDSGene Systematic Review

    T. Usnich, M. Rossi, S. Schaake, N. Schell, J. Böhm, N. Steffen, C. Krüger, R. Alcalay, K. Lohmann, C. Klein (Lübeck, Germany)

    Objective: To provide a comprehensive and systematic literature review of variants in the glucocerebrosidase 1 gene (GBA1) linked to Parkinson’s disease (PD). Background: Approximately 10% of patients with PD…
  • 2023 International Congress

    Bone Health in Parkinson’s Disease

    E. Killeen, C. Gallagher, A. Mcdonough (Dublin, Ireland)

    Objective: Optimise bone health in people with Parkinson’s Disease Background: People with Parkinson’s Disease (PD) have an increased risk of osteoporosis and associated fractures due…
  • 2023 International Congress

    Late onset cerebellar ataxia in patients treated with VIM DBS

    C. Héraud, C. Alecu, D. Fontaine, A. Leplus, C. Giordana (NICE, France)

    Objective: To highlight the predictors for onset of cerebellar ataxia in patients treated with deep brain stimulation (DBS) of the Thalamic Ventral Intermediate Nucleus (VIM)…
  • « Previous Page
  • 1
  • …
  • 169
  • 170
  • 171
  • 172
  • 173
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley